跳至主要内容
临床试验/CTRI/2019/01/017096
CTRI/2019/01/017096已完成2 期

An open labeled, randomized, comparative study to evaluate the Effectiveness of GanjhuVirTM a herbal antiviral in Cases of Dengue Fever with Thrombocytopenia

Radhika Ayurveda Research and Development0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Male or Female Subject aged between 18 and 60 years
  • 2.Diagnosis confirmed as DF Grade 1.
  • 3.Platelet count is below 100,000 and above 30,000 per µL
  • 4.ALT/SGPT level less than 165 U/L
  • 5.Subject willingly giving written informed consent

排除标准

  • 1.Patient diagnosed with DHF Grade 3 or 4
  • 2.Platelet levels are less than 30,000 per µL
  • 3.Patient is either pregnant or lactating
  • 4.Has received blood products or blood transfusion during the current hospital stay Or during last one month
  • 5.Is the patient diagnosed with ITP, Leukaemia or Hemophilia
  • 6.Serum Creatinine is more than 1.4 mg/dl (if female) or 1.5mg/dl (if male)
  • 7.Patient has participated in another trial within past one month
  • 8.Patient with positive HIV infection
  • 9.The investigator can exclude patient at his/her discretion depending upon the condition of the patient.

研究者

发起方
Radhika Ayurveda Research and Development

相似试验

Comparative study to evaluate the Effectiveness of... | 临床试验